Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for Aion Therapeutic's Days Inventory or its related term are showing as below:
XCNQ:AION's Days Inventory is not ranked *
in the Drug Manufacturers industry.
Industry Median: 165.34 * Ranked among companies with meaningful Days Inventory only.
Aion Therapeutic's Days Inventory
declined
from Jan. 2024 (274.00) to Jan. 2025 (85.19).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Aion Therapeutic's Inventory Turnover for the
three
months ended in Jan. 2025 was 1.07.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Aion Therapeutic's Inventory-to-Revenue for the
three
months ended in Jan. 2025 was 0.91.
Aion Therapeutic (XCNQ:AION) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Aion Therapeutic's Inventory Turnover for the
three
months ended in Jan. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Aion Therapeutic's Inventory to Revenue for the
three
months ended in Jan. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Aion Therapeutic Days Inventory Related Terms
Aion Therapeutic Days Inventory Historical Data
* Premium members only.
The historical data trend for Aion Therapeutic's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XCNQ:AION vs CBDY, GRPS, PLSH: Days Inventory Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Aion Therapeutic's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aion Therapeutic Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Aion Therapeutic's Days Inventory distribution charts can be found below:
* The bar in red indicates where Aion Therapeutic's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aion Therapeutic (XCNQ:AION) has a Days Inventory of 85.19 as of Jan. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Aion Therapeutic and its competitors.
Is Aion Therapeutic's Days Inventory too high?
Aion Therapeutic's current Days Inventory is 85.19. The Drug Manufacturers industry median Days Inventory is 165.34. Aion Therapeutic's value of 85.19 is 48.5% below this industry median.
How does Aion Therapeutic's Days Inventory compare to CBDY and GRPS?
Aion Therapeutic's Days Inventory of 85.19 can be compared against companies in the Drug Manufacturers industry. The industry median Days Inventory is 165.34. Aion Therapeutic's value of 85.19 is 48.5% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 165.34, based on 921 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Aion Therapeutic's current Days Inventory of 85.19 is 48.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Aion Therapeutic and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 165.34 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aion Therapeutic's current Days Inventory is 85.19. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aion Therapeutic stock overvalued right now?
Aion Therapeutic (XCNQ:AION) has a current Days Inventory of 85.19. The current Days Inventory is 85.19 and 48.5% below the Drug Manufacturers industry median of 165.34. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Aion Therapeutic (XCNQ:AION), the current Days Inventory is 85.19 as of Jan. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Aion Therapeutic Inc is in the business of research and development, treatment, data mining, and state of the art artificial intelligence techniques, focused on the development of combinatorial pharmaceuticals, nutraceuticals, and cosmeceuticals utilizing compounds from cannabis, psychedelic mushrooms, fungi, natural psychedelic formulations, and other medicinal plants in a legal environment for this type of discovery. During the year ended the Company had one operating segment, being health and wellness, dedicated to delivering state-of-the-art water filtration solutions. Geographically company earns revenue from USA.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XCNQ:AION has been successfully added to your 
